MYCN and neuroblastoma: However, 13-197, BI2536 and vismodegib were able to suppress cell growth at IC50 of 7.5-9.1 μM, 8.5-15.5 nM and 61.3-75.8 μM against MYCN-amplified neuroblastoma cells, respectively.